中藥多糖是中藥的主要化學(xué)成分之一，其結(jié)構(gòu)豐富、安全性高。近年來關(guān)于中藥多糖的生物活性報(bào)道較多，展現(xiàn)了其廣闊的開發(fā)前景。糖尿病是一類以高血糖為主要特征的代謝性疾病。據(jù)報(bào)道，中國是世界上糖尿病人口最多的國家，約占全球糖尿病患者總數(shù)的22%。通過對中藥多糖治療糖尿病的構(gòu)效關(guān)系、作用機(jī)制及其發(fā)展前景進(jìn)行綜述，為中藥多糖在糖尿病治療領(lǐng)域的開發(fā)研究提供理論依據(jù)。

Polysaccharides from traditional Chinese medicine (TCM) are one of the main chemical components of TCM, characterized by their rich structures and high safety profile. In recent years, there have been numerous reports on the biological activities of TCM polysaccharides, demonstrating their broad potential for development. Diabetes is a group of metabolic diseases primarily characterized by high blood glucose levels. It is reported that China has the largest number of people with diabetes in the world, accounting for approximately 22% of global total. By reviewing the structure-activity relationships, mechanisms of action, and development prospects of TCM polysaccharides in the treatment of diabetes, this article provides a theoretical basis for the development and research of TCM polysaccharides in the field of diabetes treatment.

R285